BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 22872456)

  • 21. Hypervascularity Predicts Complete Pathologic Response to Chemotherapy and Late Outcomes in Breast Cancer.
    Bufi E; Belli P; Di Matteo M; Giuliani M; Tumino M; Rinaldi P; Nardone L; Franceschini G; Mulé A; Bonomo L
    Clin Breast Cancer; 2016 Dec; 16(6):e193-e201. PubMed ID: 27431459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision.
    Londero V; Zuiani C; Linda A; Girometti R; Bazzocchi M; Sardanelli F
    AJR Am J Roentgenol; 2012 Aug; 199(2):W240-50. PubMed ID: 22826427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
    Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
    Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vessel analysis on contrast-enhanced MRI of the breast: global or local vascularity?
    Sardanelli F
    AJR Am J Roentgenol; 2010 Nov; 195(5):1246-9. PubMed ID: 20966335
    [No Abstract]   [Full Text] [Related]  

  • 25. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.
    Sardanelli F; Boetes C; Borisch B; Decker T; Federico M; Gilbert FJ; Helbich T; Heywang-Köbrunner SH; Kaiser WA; Kerin MJ; Mansel RE; Marotti L; Martincich L; Mauriac L; Meijers-Heijboer H; Orecchia R; Panizza P; Ponti A; Purushotham AD; Regitnig P; Del Turco MR; Thibault F; Wilson R
    Eur J Cancer; 2010 May; 46(8):1296-316. PubMed ID: 20304629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National trends and practices in breast MRI.
    Bassett LW; Dhaliwal SG; Eradat J; Khan O; Farria DF; Brenner RJ; Sayre JW
    AJR Am J Roentgenol; 2008 Aug; 191(2):332-9. PubMed ID: 18647898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-body high-field-strength (3.0-T) MR Imaging in Clinical Practice. Part I. Technical considerations and clinical applications.
    Kuhl CK; Träber F; Schild HH
    Radiology; 2008 Mar; 246(3):675-96. PubMed ID: 18309012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of whole-breast vascularity with ipsilateral breast cancers using contrast-enhanced MDCT.
    Kang DK; Kim EJ; Kim HS; Sun JS; Jung YS
    AJR Am J Roentgenol; 2008 Feb; 190(2):496-504. PubMed ID: 18212238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps.
    Schmitz AC; Peters NH; Veldhuis WB; Gallardo AM; van Diest PJ; Stapper G; van Hillegersberg R; Mali WP; van den Bosch MA
    Eur Radiol; 2008 Feb; 18(2):355-64. PubMed ID: 17882425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
    Linda A; Zuiani C; Londero V; Bazzocchi M
    Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased ipsilateral whole breast vascularity as measured by contrast-enhanced magnetic resonance imaging in patients with breast cancer.
    Wright H; Listinsky J; Quinn C; Rim A; Crowe J; Kim J
    Am J Surg; 2005 Oct; 190(4):576-9. PubMed ID: 16164924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity.
    Sardanelli F; Iozzelli A; Fausto A; Carriero A; Kirchin MA
    Radiology; 2005 Jun; 235(3):791-7. PubMed ID: 15845796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maximum intensity projection analysis in magnetic resonance of the breast.
    Carriero A; Di Credico A; Mansour M; Bonomo L
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):77-81. PubMed ID: 12585659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic Resonance in breast imaging.
    Del Maschio A; De Gaspari A; Panizza P
    Radiol Med; 2002 Oct; 104(4):253-61. PubMed ID: 12569306
    [No Abstract]   [Full Text] [Related]  

  • 35. Gadolinium-enhanced MR angiography of the breast: is breast cancer associated with ipsilateral higher vascularity?
    Mahfouz AE; Sherif H; Saad A; Taupitz M; Filimonow S; Kivelitz D; Hamm B
    Eur Radiol; 2001; 11(6):965-9. PubMed ID: 11419172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast vascular mapping obtained with contrast-enhanced MR imaging: implications for cancer diagnosis, treatment, and risk stratification.
    Sardanelli F; Fausto A; Menicagli L; Esseridou A
    Eur Radiol; 2007 Dec; 17 Suppl 6():F48-51. PubMed ID: 18376457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern concepts of ductal carcinoma in situ (DCIS) and its diagnosis through percutaneous biopsy.
    Kettritz U
    Eur Radiol; 2008 Feb; 18(2):343-50. PubMed ID: 17899107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast-enhanced MR imaging of the breast: association between asymmetric increased breast vascularity and ipsilateral cancer in a consecutive series of 197 patients.
    Verardi N; Di Leo G; Carbonaro LA; Fedeli MP; Sardanelli F
    Radiol Med; 2013 Mar; 118(2):239-50. PubMed ID: 22872456
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.